SETDB1
Basic information
Region (hg38): 1:150926263-150964744
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SETDB1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 10 | 12 | ||||
missense | 12 | 17 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 3 | 3 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 14 | 13 | 6 |
Variants in SETDB1
This is a list of pathogenic ClinVar variants found in the SETDB1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-150929964-T-C | Likely benign (Feb 01, 2023) | |||
1-150930021-A-G | Likely benign (Jul 02, 2018) | |||
1-150939931-C-T | Likely benign (Dec 31, 2019) | |||
1-150939954-A-C | Likely benign (Mar 01, 2024) | |||
1-150939977-A-G | Likely benign (Mar 01, 2024) | |||
1-150941367-A-C | not specified | Uncertain significance (Jan 04, 2022) | ||
1-150942567-C-T | Likely benign (Apr 25, 2018) | |||
1-150942666-C-G | Likely benign (Apr 16, 2018) | |||
1-150942850-A-G | Uncertain significance (Aug 01, 2018) | |||
1-150942901-A-G | Likely benign (Jan 19, 2018) | |||
1-150942957-T-C | not specified | Uncertain significance (Jun 29, 2022) | ||
1-150943990-C-G | not specified | Uncertain significance (Jul 26, 2021) | ||
1-150944928-T-C | Likely benign (Apr 25, 2018) | |||
1-150945146-G-GT | Benign (Mar 03, 2015) | |||
1-150946983-A-G | not specified | Uncertain significance (Apr 13, 2022) | ||
1-150947007-A-G | not specified | Uncertain significance (Apr 08, 2022) | ||
1-150949193-C-T | Likely benign (Jan 31, 2018) | |||
1-150949261-C-G | Benign (Jan 30, 2018) | |||
1-150949438-C-T | not specified | Uncertain significance (Mar 15, 2024) | ||
1-150950463-C-T | Benign (Dec 31, 2019) | |||
1-150950706-G-A | Uncertain significance (Mar 31, 2022) | |||
1-150950930-G-A | not specified | Uncertain significance (Mar 20, 2024) | ||
1-150951098-G-C | Likely benign (Jul 27, 2018) | |||
1-150951416-A-G | Likely benign (Aug 20, 2018) | |||
1-150951422-C-G | Likely benign (Mar 30, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SETDB1 | protein_coding | protein_coding | ENST00000271640 | 21 | 38475 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.00000446 | 125736 | 0 | 12 | 125748 | 0.0000477 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 4.01 | 434 | 741 | 0.586 | 0.0000424 | 8483 |
Missense in Polyphen | 120 | 350.29 | 0.34257 | 4030 | ||
Synonymous | -0.378 | 275 | 267 | 1.03 | 0.0000141 | 2536 |
Loss of Function | 6.69 | 7 | 65.4 | 0.107 | 0.00000402 | 707 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000291 | 0.0000291 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000704 | 0.0000703 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Histone methyltransferase that specifically trimethylates 'Lys-9' of histone H3. H3 'Lys-9' trimethylation represents a specific tag for epigenetic transcriptional repression by recruiting HP1 (CBX1, CBX3 and/or CBX5) proteins to methylated histones. Mainly functions in euchromatin regions, thereby playing a central role in the silencing of euchromatic genes. H3 'Lys-9' trimethylation is coordinated with DNA methylation. Probably forms a complex with MBD1 and ATF7IP that represses transcription and couples DNA methylation and histone 'Lys-9' trimethylation. Its activity is dependent on MBD1 and is heritably maintained through DNA replication by being recruited by CAF-1. SETDB1 is targeted to histone H3 by TRIM28/TIF1B, a factor recruited by KRAB zinc-finger proteins. Probably forms a corepressor complex required for activated KRAS-mediated promoter hypermethylation and transcriptional silencing of tumor suppressor genes (TSGs) or other tumor-related genes in colorectal cancer (CRC) cells (PubMed:24623306). Also required to maintain a transcriptionally repressive state of genes in undifferentiated embryonic stem cells (ESCs) (PubMed:24623306). Associates at promoter regions of tumor suppressor genes (TSGs) leading to their gene silencing (PubMed:24623306). The SETDB1-TRIM28-ZNF274 complex may play a role in recruiting ATRX to the 3'-exons of zinc-finger coding genes with atypical chromatin signatures to establish or maintain/protect H3K9me3 at these transcriptionally active regions (PubMed:27029610). {ECO:0000269|PubMed:12869583, ECO:0000269|PubMed:14536086, ECO:0000269|PubMed:15327775, ECO:0000269|PubMed:17952062, ECO:0000269|PubMed:24623306, ECO:0000269|PubMed:27029610}.;
- Pathway
- Lysine degradation - Homo sapiens (human);Signaling pathways regulating pluripotency of stem cells - Homo sapiens (human);Histone Modifications;PKMTs methylate histone lysines;Chromatin modifying enzymes;Lysine metabolism;Noncanonical Wnt signaling pathway;Chromatin organization
(Consensus)
Intolerance Scores
- loftool
- 0.0153
- rvis_EVS
- -1.46
- rvis_percentile_EVS
- 3.81
Haploinsufficiency Scores
- pHI
- 0.134
- hipred
- Y
- hipred_score
- 0.833
- ghis
- 0.615
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 1.00
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Setdb1
- Phenotype
- cellular phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); embryo phenotype;
Gene ontology
- Biological process
- Ras protein signal transduction;response to vitamin;histone lysine methylation;response to ethanol;positive regulation of methylation-dependent chromatin silencing
- Cellular component
- nucleus;nucleoplasm;chromosome;cytosol;plasma membrane;intracellular membrane-bounded organelle
- Molecular function
- DNA binding;chromatin binding;protein binding;zinc ion binding;histone-lysine N-methyltransferase activity;promoter-specific chromatin binding